文献速递胃肠动力与功能性疾病

每日一次质子泵抑制剂治疗失败的胃食管反流病患者多数合并功能性食管疾病

Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-06-18

该研究纳入每日一次质子泵抑制剂(PPI)治疗后仍有症状的胃食管反流病(GERD)患者16例(PPI失败组)与症状完全缓解者13例(PPI成功组),行阻抗-pH监测。两组pH异常比例无显著差异(失败组25% vs 成功组31%,P=1.00),阻抗与pH参数亦无显著差异;PPI失败组75%存在功能性烧心或反流高敏感。

要点

  • PPI失败组75%存在功能性烧心或反流高敏感等功能性食管疾病。
  • PPI失败组与成功组pH异常比例无显著差异(25% vs 31%,P=1.00)。
  • 两组阻抗与pH参数无显著差异。

核心结论

  • 每日一次PPI治疗成功与失败的GERD患者之间反流特征无差异。
  • PPI失败组中75%存在功能性食管疾病。

研究设计与样本

  • 研究纳入每日一次标准剂量PPI治疗下仍每周至少2次烧心和/或反流持续3个月的患者为PPI失败组(n=16)。
  • 每日一次PPI治疗至少4周症状完全缓解的患者为PPI成功组(n=13)。
  • 收集人口学数据,受试者完成短表36(SF-36)与GERD健康相关生活质量问卷。
  • 患者在PPI治疗期间接受上消化道内镜与食管阻抗-pH联合监测。

主要发现

  • PPI成功组4例(31%)与PPI失败组4例(25%)pH试验结果异常(P=1.00)。
  • PPI失败组75%存在功能性烧心或反流高敏感合并GERD。
  • PPI失败组与成功组之间阻抗与pH参数无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: As many as 45% of patients with gastroesophageal reflux disease (GERD) still have symptoms after receiving once-daily proton pump inhibitor (PPI) therapy. We aimed to compare reflux characteristics and patterns between responders and non-responders to once-daily PPI therapy using combined impedance-pH monitoring. METHODS: Patients who reported heartburn and/or regurgitation at least twice per week for 3 months while receiving standard-dose PPI therapy were assigned to the PPI failure group (n = 16). Patients who reported a complete resolution of symptoms on once-daily PPIs for at least 4 weeks were assigned to the PPI success group (n = 13). We collected demographic data and subjects completed the short-form 36 and the GERD health-related quality of life questionnaires. Patients then underwent upper endoscopy and combined esophageal impedance-pH monitoring while on PPI therapy. RESULTS: Four patients in the PPI success group (31%) and 4 patients in the PPI failure group (25%) had abnormal results from the pH test (P = 1.00). Most of the patients in the PPI failure group (75%) were found to have either functional heartburn or reflux hypersensitivity with GERD. Impedance and pH parameters did not differ significantly between the PPI failure and success group. CONCLUSIONS: We found no difference in reflux characteristics between patients with GERD who had successful vs failed once-daily PPI therapy. Most patients in the PPI failure group (75%) had functional esophageal disorders.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Abdallah J, George N, Yamasaki T, et al. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders. Clin Gastroenterol Hepatol. 2018. PMID: 29913281. doi:10.1016/j.cgh.2018.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。